Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Multiple-breath inhalational induction |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Induction of general anesthesia |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Intravenous induction by target-controlled infusion |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Inhaled steroid therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
3 |
Administration of prophylactic coagulation factor Xa inhibitor |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of prophylactic direct thrombin inhibitor |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Mesalamine therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Levothyroxine therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Stimulant therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Alcohol-oxygen vapor therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Alcohol-oxygen vapor therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Corticosteroid and/or corticosteroid derivative therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Diagnostic intravenous injection of edrophonium |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of total parenteral nutrition |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only Measles morbillivirus and Rubella virus antigens |
Method |
False |
Administration - action |
Inferred relationship |
Existential restriction modifier |
3 |
Administration of consolidation antineoplastic agent |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Augmentation of labor using oxytocin |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of ergometrine and oxytocin |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of ergometrine and oxytocin |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Short-term drug therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only Dengue virus antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of hyperthermic antineoplastic agent into peritoneal cavity |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of hyperthermic antineoplastic agent into thoracic cavity |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of prophylactic platelet aggregation inhibitor |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of prophylactic platelet aggregation inhibitor |
Method |
False |
Administration - action |
Inferred relationship |
Existential restriction modifier |
3 |
Platelet aggregation inhibitor therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Platelet aggregation inhibitor therapy |
Method |
False |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Administration of substance via enteral route |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of insulin using insulin pump |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of substance via gastroenteral route |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Antenatal therapeutic administration of corticosteroid |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Ocrelizumab therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of prophylactic anti-infective agent for Pneumocystosis jirovecii pneumonia |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of booster dose of vaccine product containing only Hepatitis A virus antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Administration of vaccine product containing only Measles morbillivirus and Rubella virus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of booster dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of antiarrhythmic drug via oral route |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of second dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of first dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of booster dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of multimodal anesthesia |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of prophylactic drug or medicament for graft-versus-host disease |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of second dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of first dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of third dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Folinic acid, fluorouracil and irinotecan antineoplastic chemotherapy regimen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Folinic acid, fluorouracil and irinotecan antineoplastic chemotherapy regimen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Folinic acid, fluorouracil and irinotecan antineoplastic chemotherapy regimen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
3 |
Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
3 |
Fluorouracil, leucovorin, irinotecan and oxaliplatin antineoplastic chemotherapy regimen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
4 |
Proton pump inhibitor therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Vasopressor therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Immune checkpoint inhibitor therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Artesunate therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Heated and humidified high flow oxygen therapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of human anti-D immunoglobulin |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of remdesivir |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of third dose of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Preschool administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Preschool administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of essential fatty acid |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen in oral dose form |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of second dose of pediatric vaccine product containing only Hepatitis A virus antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of third dose of pediatric vaccine product containing only Hepatitis A virus antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of booster dose of pediatric vaccine product containing only Hepatitis A virus antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of second dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of first dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only Human papillomavirus 6, 11, 16 and 18 antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of pneumococcal 7-valent conjugate vaccine |
Method |
False |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of booster dose of vaccine product containing only Neisseria meningitidis serogroup C antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of first dose of vaccine product containing only Neisseria meningitidis serogroup B antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of first dose of vaccine product containing only Human alphaherpesvirus 3 and Measles morbillivirus and Mumps orthorubulavirus and Rubella virus antigens |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of RhD immune globulin |
Method |
False |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Intravenous infusion of Cytomegalovirus immune globulin |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Administration of human anti-D immunoglobulin |
Method |
False |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of parenteral nutrition |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of sedative via nasal route |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of multiple antineoplastic agents |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of prophylactic antiviral |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Administration of prophylactic antifungal |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Antineoplastic chemoimmunotherapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Antineoplastic chemoimmunotherapy |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
2 |
Increased polyunsaturated fat diet |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |
Decreased potassium diet |
Method |
True |
Administration - action |
Inferred relationship |
Existential restriction modifier |
1 |